Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Incannex Healthcare (IXHL) EBIT Margin (2024 - 2025)

Incannex Healthcare's EBIT Margin history spans 2 years, with the latest figure at 139900.0% for Q4 2025.

  • For Q4 2025, EBIT Margin fell 9820000.0% year-over-year to 139900.0%; the TTM value through Dec 2025 reached 263200.0%, down 23014884.0%, while the annual FY2025 figure was 27661.63%, 22268004.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 139900.0% at Incannex Healthcare, down from 135880.0% in the prior quarter.
  • Across five years, EBIT Margin topped out at 8451.35% in Q3 2024 and bottomed at 139900.0% in Q4 2025.